Assessment of Acromegaly Patients With and Without Diabetes Treated With Lanreotide Depot/Autogel (LAN): 2-Year Registry Study Data
AACE ePoster Library. GORDON M. May 27, 2016; 131507
Disclosure(s): MBG: Clinical research funding: Ipsen, Novartis, Pfizer, Novo Nordisk, Teva, Opko, Corcept MM: Advisory board/consultant: Ipsen, Novartis, Chiasma, Corcept; clinical research funding: Ipsen, Novartis WWW: Advisory board: Chiasma; clinical research funding: Ipsen, Versartis, Novo Nordisk DWC: Consultant: Ipsen Biopharmaceuticals OVG, BM, DC: Employees: Ipsen Biopharmaceuticals RS: Advisory board/consultant: Novartis, Novo Nordisk; clinical research funding: Ipsen, Pfizer, Novartis
MURRAY GORDON
MURRAY GORDON
Login now to access Regular content available to all registered users.
Rate & Comment (0)
    This eLearning portal is powered by:
    This eLearning portal is powered by MULTIEPORTAL
Anonymous User Privacy Preferences

Strictly Necessary Cookies (Always Active)

MULTILEARNING platforms and tools hereinafter referred as “MLG SOFTWARE” are provided to you as pure educational platforms/services requiring cookies to operate. In the case of the MLG SOFTWARE, cookies are essential for the Platform to function properly for the provision of education. If these cookies are disabled, a large subset of the functionality provided by the Platform will either be unavailable or cease to work as expected. The MLG SOFTWARE do not capture non-essential activities such as menu items and listings you click on or pages viewed.


Performance Cookies

Performance cookies are used to analyse how visitors use a website in order to provide a better user experience.


Save Settings